JP2024529534A5 - - Google Patents
Info
- Publication number
- JP2024529534A5 JP2024529534A5 JP2024506646A JP2024506646A JP2024529534A5 JP 2024529534 A5 JP2024529534 A5 JP 2024529534A5 JP 2024506646 A JP2024506646 A JP 2024506646A JP 2024506646 A JP2024506646 A JP 2024506646A JP 2024529534 A5 JP2024529534 A5 JP 2024529534A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- halo
- pharmaceutically acceptable
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229861P | 2021-08-05 | 2021-08-05 | |
| US63/229,861 | 2021-08-05 | ||
| PCT/US2022/039385 WO2023014861A1 (en) | 2021-08-05 | 2022-08-04 | Pparg inverse agonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529534A JP2024529534A (ja) | 2024-08-06 |
| JP2024529534A5 true JP2024529534A5 (enExample) | 2025-08-13 |
Family
ID=83149096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506646A Pending JP2024529534A (ja) | 2021-08-05 | 2022-08-04 | Ｐｐａｒｇ逆アゴニストおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250122169A1 (enExample) |
| EP (1) | EP4380928B1 (enExample) |
| JP (1) | JP2024529534A (enExample) |
| AU (1) | AU2022323260A1 (enExample) |
| CA (1) | CA3227603A1 (enExample) |
| WO (1) | WO2023014861A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7853310B2 (ja) * | 2021-03-02 | 2026-04-28 | フレア・セラピューティクス・インコーポレーテッド | Ｐｐａｒｇ逆アゴニストおよびその使用 |
| SMT202500447T1 (it) * | 2021-11-02 | 2026-01-12 | Flare Therapeutics Inc | Agonisti inversi di pparg e loro usi |
| CA3254026A1 (en) * | 2022-03-08 | 2023-09-14 | Flare Therapeutics Inc. | Inverse PPARG agonists and their uses |
| AU2023231613A1 (en) * | 2022-03-08 | 2024-09-05 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
| IL316422A (en) * | 2022-04-22 | 2024-12-01 | Vertex Pharma | Heteroaryl compounds for pain treatment |
| WO2024211969A1 (en) * | 2023-04-12 | 2024-10-17 | Setonix Pharmaceuticals Pty Ltd | Pparg modulators |
| WO2024221455A1 (en) * | 2023-04-28 | 2024-10-31 | Flare Therapeutics, Inc. | Crystalline forms of 3- (5, 7-difluoro-4-oxo-1, 4-dihydroquinolin-2-yl) -4- (methylsulfonyl) benzonitrile |
| WO2026046259A1 (zh) * | 2024-08-27 | 2026-03-05 | 杭州英创医药科技有限公司 | 作为pparg反向激动剂的化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077712A1 (es) * | 2009-08-05 | 2011-09-14 | Idenix Pharmaceuticals Inc | Inhibidores de serina proteasa macrociclica |
| WO2011054433A1 (en) * | 2009-11-07 | 2011-05-12 | Merck Patent Gmbh | Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| EP3371151A4 (en) * | 2015-10-09 | 2019-03-27 | Agency For Science, Technology And Research | COMPOUNDS FOR THE TREATMENT OF CANCER AND EPIGENETICS |
| CN107522657B (zh) * | 2017-09-28 | 2020-06-26 | 上海中医药大学 | 一种具有ppar多重激动活性的化合物及其制备方法和应用 |
| US12479803B2 (en) * | 2019-04-03 | 2025-11-25 | University Of Central Florida Research Foundation, Inc. | Antimalarial compounds |
| JP7853310B2 (ja) * | 2021-03-02 | 2026-04-28 | フレア・セラピューティクス・インコーポレーテッド | Ｐｐａｒｇ逆アゴニストおよびその使用 |
-
2022
- 2022-08-04 JP JP2024506646A patent/JP2024529534A/ja active Pending
- 2022-08-04 EP EP22761764.4A patent/EP4380928B1/en active Active
- 2022-08-04 AU AU2022323260A patent/AU2022323260A1/en active Pending
- 2022-08-04 CA CA3227603A patent/CA3227603A1/en active Pending
- 2022-08-04 US US18/294,768 patent/US20250122169A1/en active Pending
- 2022-08-04 WO PCT/US2022/039385 patent/WO2023014861A1/en not_active Ceased